📰 Coagulation Disorders Program News
Coagulation Disorders Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Coagulation Disorders Program. Real-time updates on events, politics, business and more.
August 30, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
August 30, 2022
The U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for efanesoctocog alfa (BIVV001) for the treatment of hemophilia A, a rare and life-threatening bleeding disorder. The target action date for the FDA decision is February 28, 2023. Sanofi and Sobi® ...
December 14, 2021
Monthly infusion vs on-demand bypassing agents effective in patients with or without inhibitors